News

/News/

United Kingdom Proposes Applying Price Controls to Biosimilars

The government has launched a consultation that outlines the proposed changes to its price controls, which require brand-name drug makers to pay the government 7.8% of their sales of products to the National Health Service.

Read the full article by Kelly Davio here.

By |2018-08-17T13:57:15+00:00August 17th, 2018|News|0 Comments

We are expanding! Pricing and Market Access Consultant required

Remap Consulting is searching for talented, enthusiastic individuals to join our expanding team. We are looking for candidates with an entrepreneurial spirit, passion for pharmaceutical pricing and market access and a keen eye for detail who are interested in joining our bespoke pricing and market access consultancy, in a Consultant role based at Alderley Park in Cheshire.

Please email us with a covering letter and your CV to contact@remapconsulting.com

Consultant role

By |2018-08-16T15:06:39+00:00August 16th, 2018|News, Uncategorized|0 Comments

Will an EU-wide HTA clinical assessment become a reality?

The European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health technology assessment (HTA), to determine the clinical efficacy of a product. The aim of the proposal is to improve patient access and reduce resources (from both a member state and pharmaceutical industry perspective) required to determine the clinical effectiveness of new treatments. However, will this be the case in practice, or will this new EU legislation result in an additional hurdle to achieving patient access, requiring additional resources?

The EC’s case for an EU wide HTA clinical assessment is based on some well-grounded realities:

  • Currently, market access for innovative technologies is impeded and distorted due to differing national or regional processes and methodologies for HTAs and decision makers across Europe
  • There is a lack of business predictability, higher costs for industry, delays in access to technologies, and negative effects on innovation
  • There is significant […]
By |2018-07-25T13:20:32+00:00July 25th, 2018|News|0 Comments

Recent changes to NICE’s STA appraisal process and the CDF. What does this mean for manufacturers?

On 26th June 2018, Remap Consulting had the pleasure of attending the annual National Institute of Health and Care Excellence (NICE) conference. The event provided a great opportunity to network with NICE and industry and to discuss recent updates to NICE processes, including the new Cancer Drugs Fund (CDF) and the new Single Technology Appraisal (STA) process.

Two-years into the new CDF: what are the learnings?

In July 2016, NICE launched the new Cancer Drugs Fund (CDF), which allows one of three recommendations for oncology products; a positive recommendation, a negative recommendation, or a recommendation for use within the CDF. Products which are recommended within the CDF are subject to a managed access agreement (MAA), which consists of three components:

  1. Data collection agreements either in the form of clinical trials run by the manufacturer or through the use of real-world evidence (for instance through the use of Public Health […]
By |2018-07-11T12:29:25+00:00July 6th, 2018|News|0 Comments

We are hiring…. an Analyst

Remap Consulting is searching for talented, enthusiastic individuals to join our expanding team. We are looking for candidates with an entrepreneurial spirit, passion for pharmaceutical pricing and market access and a keen eye for detail who are interested in joining our bespoke pricing and market access consultancy, in an analyst role.

For further information about the role including the requirements and the benefits we have to offer, please click here.

By |2018-07-27T10:06:40+00:00July 5th, 2018|News|0 Comments

Remap Consulting are attending the NICE 2018 annual conference today

Remap Consulting are looking forward to attending the NICE 2018 Conference today. The theme of the day is improving health, improving lives which will showcase the latest developments in clinical improvement, health technologies and patient-centred quality care. Read more here

 

By |2018-06-26T08:05:44+00:00June 26th, 2018|News|0 Comments

A day in the life of….. a Training & Operations Manager

What is a typical day like in the life of a Remap Consulting Operations & Training Manager?

I have been working within the market access consultancy industry for the last 4 years, working my way up from a project administrator to a training and operations manager. I work as part of a close-knit team of pricing and market access experts including; directors, consultants, analysts and project administrators on a variety of projects that are focused in three main areas; pricing and market access launch, market access training and price optimisation.

I struggle to describe a ‘typical day’ in my role as a training and operations manager as every day is different, with each day bringing new projects and challenges. Driving into the office around 8.00am watching the lambs frolicking in the fields of the on-site farm, the first thing on my mind is a cup of tea! My first challenge […]

By |2018-08-06T14:57:40+00:00June 21st, 2018|News|0 Comments

Remap proud to be part of the Northwest Biotech Initiative

Charles Hewitt and Fatima Chunara had a great day on saturday mentoring and supporting the students at the Northwest Biotech Initiative Case Competition, where we were very proud to have sponsored the best speaker prize. Charles Hewitt also gave a great presentation on why he chose a career in consulting and the skills needed to thrive in the industry. #NWBICCC2018 

By |2018-06-11T12:52:55+00:00June 11th, 2018|News|0 Comments

Join Remap at the Northwest Biotech Initiative – Saturday 9th June

Remap are extremely proud to be sponsoring the best speaker prize tomorrow at the Northwest Biotech Initiative Annual Consulting Case Competition. Our very own Charlie Hewitt will be talking about Strategic Consultancy within the pharmaceutical industry and how you can become a Consultant. If you are in and around Manchester tomorrow, come and join us!

By |2018-06-08T14:56:59+00:00June 8th, 2018|News|0 Comments